SUNDAY 10 OCTOBER 2021
Plenary session 3 Viral infection associated Pulmonary Aspergillosis / Going Viral Going Fungal
Chair: Tihana Bicanic, UK, FECMM
09:00
PS3.1 Influenza
Paul Verweij, the Netherlands, FECMM
09:30
PS3.2 COVID-19
Martin Hoenigl, Austria, FECMM
10:00
Coffee break
10:15
Quiz the expert sessions
10:15
Q07 MIC testing in the lab
Maiken Arendrup, Denmark
10:15
Q08 Mucormycosis how to manage
Livio Pagano, Italy, FECMM & Sharon Chen, Australia, FECMM
10:15
Q09 TDM
Andreas Groll, FECMM
10:15
Q10 Radiology
Joanne Cleverley, UK
10:15
Q11 How to use new antifungals in kids
Fabianne Carlesse, Brazil
10:15
Q12 Mycological Diagnosis on the bedside: Where are we in 2021
John Perfect, USA & Toine Mercier, Belgium, FECMM
11:00
Poster session 2
12:00
Lunch
12:30
Sponsored Integrated Symposium 4
More information on www.timm2021.org/sponsored-symposia
14:15
Parallel Symposia 14-17
Symposium 14 Fungal respiratory infections in Cystic Fibrosis
Chairs: Jean-Philippe Bouchara, France & Michaela Lackner, Austria, FECMM
14:15
S14.1 Fungal infections in patients with cystic fibrosis
Michaela Lackner, Austria, FECMM
14:35
S14.2 Exophiala dermatitidis in cystic fibrosis
Jörg Steinmann, Germany, FECMM
14:55
S14.3 Immunotherapy
Darius Armstrong-James, UK
Symposium 15 Cryptococosis: From bench to bedside
14:15
S15.1 Cryptococcus qPCR assays: the future for routine mycology labs and clinical trials dealing with cryptococcosis – An AMBITION sub-study
Alexandre Alanio, FR, FECMM
14:35
S15.2 AMBITION trial and beyond
Joe Jarvis, UK
14:55
S15.3 Titan cells in cryptococcosis
Liz Ballou, UK
15:15
S15.4 Modifications of the cell wall in cryptococcosis
Liliane Mukaremera, UK
Symposium 16 Azoles, Echinocandins and Polyenes strenghts and weaknesses
Chairs: Frederic Lamoth, Switzerland, FECMM & Marika Jürna-Ellam, Spain
14:15
S16.1 Azoles
14:35
S16.2 Echinocandins
Andrej Spec, USA, FECMM
14:55
S16.3 Polyenes and biofilms
Gordon Ramage, UK
15:15
S16.4 Breakthrough infections - Definitions, Epidemiology and Outcomes
Jeff Jenks, USA
Symposium 17 Management of immunoallergic fungal diseases
Chairs: Tom Rogers, Ireland
14:15
S17.1 Antifungal treatment in kids with allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization : where do we stand?
Adilia Warris, UK, FECMM
14:35
S17.2
Peter Cook, UK
14:55
S17.3 Impact of environmental approaches for allergen avoidance and asthma control
Jean-Pierre Gangneux, France, FECMM
15:15
S18.4 Mycology laboratory diagnostic capabilities in different areas of the world
15:45
Coffee break
16:15
Parallel Symposia 18-21
Symposium 18 Diagnosis of invasive aspergillosis: What is new?
Chair: Lewis White, UK, FECMM
16:15
S18.1 Maldi
16:35
S18.2 POC
Juergen Prattes, Austria, FECMM
16:55
S18.3 PCR Diagnosis
Lewis White, UK, FECMM
Symposium 19 Pre clinical anti fungal studies
Chairs: Alexandra Brand, UK & Mihai Mares, Romania, FECMM
16:15
S19.1 Tracking antifungals in the cell
Judy Berman, Israel
16:35
S19.2 Paradoxical growth
Carol Munro, UK
16:55
S19.3 Screens for new compounds
17:15
S19.4 Animal models
David Andes, USA
Symposium 20 Improving outcomes for patients with invasive fungal infection in routine care in LMIC
Chair: Rita Oladele, Nigeria, FECMM
16:15
S20.1 From trials to routine care - strengthening pathways to effective implementation – lessons from cryptococcal meningitis and the UNITAID/CHAI programme for advanced HIV disease
Angela Loyse, UK
16:35
S20.2 CDC Mycology Branch programme to support diagnosis and treatment in LMIC
16:55
S20.3 Improving outcomes for patients with histoplasmosis, mycetoma and chromoblastomycosis in South America
Flavio Queiros Telles, Brazil
Symposium 21 Invasive fungal infections in special populations
Chair: Volkan Özenci, Sweden
16:15
S21.1 Neonatal candiasis
Tom Walsh, UK, FECMM
16:35
S21.2 ECMO and dialysis
Robert Krause, Austria, FECMM
16:55
S21.3 Obese patients
Roger Brüggemann, the Netherlands, FECMM
18:00
Sponsored Diagnostic Symposium 2
More information on https://www.timm2021.org/sponsored-symposia/
19:30
Congress dinner
Plenary session 3 Viral infection associated Pulmonary Aspergillosis / Going Viral Going Fungal
Chair: Tihana Bicanic, UK, FECMM
09:00
PS3.1 Influenza
Paul Verweij, the Netherlands, FECMM
09:30
PS3.2 COVID-19
Martin Hoenigl, Austria, FECMM
10:00
Coffee break
10:15
Quiz the expert sessions
10:15
Q07 MIC testing in the lab
Maiken Arendrup, Denmark
10:15
Q08 Mucormycosis how to manage
Livio Pagano, Italy, FECMM & Sharon Chen, Australia, FECMM
10:15
Q09 TDM
Andreas Groll, FECMM
10:15
Q10 Radiology
Joanne Cleverley, UK & Bruno Hochhegger, FECMM, Brazil
10:15
Q11 How to use new antifungals in kids
Fabianne Carlesse, Brazil
10:15
Q12 Mycological Diagnosis on the bedside: Where are we in 2021
John Perfect, USA & Toine Mercier, Belgium, FECMM
11:00
Poster session 2
12:00
Lunch
12:30
Sponsored Integrated Symposium 4
More information on www.timm2021.org/sponsored-symposia
14:15
Parallel Symposia 14-17
Symposium 14 Fungal respiratory infections in Cystic Fibrosis
Chairs: Jean-Philippe Bouchara, France & Michaela Lackner, Austria, FECMM
14:15
S14.1 Fungal infections in patients with cystic fibrosis
Michaela Lackner, Austria, FECMM
14:35
S14.2 Exophiala dermatitidis in cystic fibrosis
Jörg Steinmann, Germany, FECMM
14:55
S14.3 Immunotherapy
Darius Armstrong-James, UK
Symposium 15 Cryptococosis: From bench to bedside
14:15
S15.1 Advancing prevention and treatment of HIV-associated cryptococcal meningitis
14:35
S15.2 AMBITION trial and beyond
Joe Jarvis, UK
14:55
S15.3 Titan cells in cryptococcosis
Liz Ballou, UK
15:15
S15.4 Modifications of the cell wall in cryptococcosis
Liliane Mukaremera, UK
Symposium 16 Azoles, Echinocandins and Polyenes strenghts and weaknesses
Chair: Frederic Lamoth, Switzerland, FECMM
14:15
S16.1 Azoles
14:35
S16.2 Echinocandins
Andrej Spec, USA, FECMM
14:55
S16.3 Polyenes and biofilms
Gordon Ramage, UK
15:15
S16.4 Breakthrough infections - Definitions, Epidemiology and Outcomes
Jeff Jenks, USA
Symposium 17 Management of immunoallergic fungal diseases
14:15
S17.1 Antifungal treatment in kids with allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization : where do we stand?
Adilia Warris, UK, FECMM
14:35
S17.2
Peter Cook, UK
14:55
S17.3 Impact of environmental approaches for allergen avoidance and asthma control
Jean-Pierre Gangneux, France, FECMM
15:15
S18.4 Mycology laboratory diagnostic capabilities in different areas of the world
15:45
Coffee break
16:15
Parallel Symposia 18-21
Symposium 18 Diagnosis of invasive aspergillosis: What is new?
Chair: Lewis White, UK, FECMM
16:15
S18.1 Maldi
16:35
S18.2 POC
Juergen Prattes, Austria, FECMM
16:55
S18.3 PCR Diagnosis
Lewis White, UK, FECMM
Symposium 19 Pre clinical anti fungal studies
Chairs: Alexandra Brand, UK & Mihai Mares, Romania, FECMM
16:15
S19.1 Tracking antifungals in the cell
Judy Berman, Israel
16:35
S19.2 Paradoxical growth
Carol Munro, UK
16:55
S19.3 Screens for new compounds
17:15
S19.4 Animal models
David Andes, USA
Symposium 20 Improving outcomes for patients with invasive fungal infection in routine care in LMIC
Chair: Rita Oladele, Nigeria, FECMM
16:15
S20.1 From trials to routine care - strengthening pathways to effective implementation – lessons from cryptococcal meningitis and the UNITAID/CHAI programme for advanced HIV disease
Angela Loyse, UK
16:35
S20.2 CDC Mycology Branch programme to support diagnosis and treatment in LMIC
16:55
S20.3 Improving outcomes for patients with histoplasmosis, mycetoma and chromoblastomycosis in South America
Flavio Queiros Telles, Brazil
Symposium 21 Invasive fungal infections in special populations
Chair: Volkan Özenci, Sweden
16:15
S21.1 Neonatal candiasis
Tom Walsh, UK, FECMM
16:35
S21.2 ECMO and dialysis
Robert Krause, Austria, FECMM
16:55
S21.3 Obese patients
Roger Brüggemann, the Netherlands, FECMM
18:00
Sponsored Diagnostic Symposium 2
More information on https://www.timm2021.org/sponsored-symposia/
19:30
Congress dinner